Ophthotech Corp (OPHT), Novartis Enter ex-US Licensing Agreement for Wet …
StreetInsider.com (subscription) Ophthotech Corporation (Nasdaq: OPHT) announced that the Company has entered into an ex-US licensing and commercialization agreement with Novartis Pharmaceuticals (NYSE: NVS) focused on the treatment of wet age-related macular degeneration … Novartis announces exclusive agreement to extend leadership in ophthalmology …MarketWatch Ophthotech licenses experimental eye drug to NovartisWTAQ Ophthotech Corp. (OPHT) Is Up Sharply After Novartis AgreementRTT News |
Source: Wet Macular Degeneration News From Google News
Zennie Abraham | Zennie Abraham or “Zennie62” is the founder of Zennie62Media which consists of zennie62blog.com and a multimedia blog news aggregator and video network, and 78-blog network, with social media and content development services and consulting. Zennie is a pioneer video blogger, YouTube Partner, social media practitioner, game developer, and pundit. Note: news aggregator content does not reflect the personal views of Mr. Abraham.